AFA FR - Digoxin Information Sheet.indd - Santé Et Remise En Forme

PDF,PPT,images:AFA FR - Digoxin Information Sheet.indd - Santé Et Remise En Forme

AFA Australia Digoxin FACT sheet - heartrhythmallianceorg

Digoxin - Patient Information Digoxin Digoxin is a medication that has been used for many years It was fi rst described by a doctor from Birmingham called William Withering in 1785 when he found that extracting the sap of the foxglove could help patients suff ering with ‘Dropsy’ (what we would now call heart failure)

Read Highlighted Changes Revised February 2009 Digoxin

digoxin in the sample and the RLUs detected by the ARCHITECT i System optics For additional information on system and assay technology, refer to the ARCHITECT System Operations Manual, Section 3 REAGENTS Reagent Kit, 100 Tests Note: Some kit sizes are not available in all countries or for use on all ARCHITECT i Systems Please contact your

Digitoxin - Ilex Medical Ltd

1999/45/EC as amended - Safety data sheet available for professional user on request HANDLING PRECAUTIONS Do not use kits beyond the expiration date or a maximum of 224 cumulative hours on-board the AxSYM System Do not mix reagents from different reagent packs Refer to the AxSYM System Operations Manual, Sections 7 and 8, for a

INDICATIONS & USAGE THE RELIEF OF THE SIGNS AND SYMPTOMS OF

Digoxin: Concomitant use with NAPROSYN Suspension can increase serum concentration and prolong half-life of digoxin Monitor serum digoxin levels (7) USE IN SPECIFIC POPULATIONS Pregnancy: Use of NSAIDs during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus Avoid use of

AFA Australia Atrial Flutter FACT sheet

Atrial Flutter - Patient Information 2 Medication: Medication (such as beta blockers, calcium channel blockers or digoxin, sometimes in combination) can be used either to slow the heart rate without actually stopping the fl utter This approach is less successful for atrial fl utter than for atrial fi brillation

Heart Failure

Patient information Fact Sheet include aminophylline and theophylline, hydralazine and prazosin Three drugs from a class called the beta-blockers can now be prescribed for heart failure in certain circumstances These are bisoprolol (Zebeta), carvedilol (Coreg) and nebivolol (Bystolic)

Dosage Form Design: Pharmaceutical and Formulation Considerations

type of information needed to defi ne the nature of the drug substance This information provides the framework for the drug’s combination with pharmaceutical ingredients in the fabrication of a dosage form Physical Description It is important to understand the physical descrip-tion of a drug substance prior to dosage form development

BENZTROPINE - neiglobalcom

of pregnancy and lactation information in prescription drug labels, including the elimination of the pregnancy letter categories; the Pregnancy and Lactation Labeling Rule (PLLR or fi nal rule) applies only to prescription drugs and will be phased in gradually for drugs approved on or after June 30, 2001

(spironolactone and benazepril hydrochloride chewable tablets)

Contact Information: To report suspected adverse events or to request a copy of the Safety Data Sheet (SDS), please call Ceva Animal Health at 1-800-999-0297 For additional information about adverse drug experience reporting for animal drugs, contact

Images may be subject to copyright Report CopyRight Claim

×